Erratum: Fluoroquinolone-resistant pseudomonas aeruginosa in chronic rhinosinusitis (ORL (2009) 71 (263-267) DOI: 10.1159/000242428);Fluoroquinolone-resistant pseudomonas aeruginosa in chronic rhinosinusitis

ORL

Volumn 71, Issue 5, 2009, Pages 263-267

  Guss, Joel ^a   Doghramji, Laurel ^a   Edelstein, Paul H ^a   Chiu, Alexander G ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Ciprofloxacin; Fluoroquinolone; Levofloxacin; Pseudomonas aeruginosa; Rhinosinusitis; Sinusitis

Indexed keywords

AMINOGLYCOSIDE; CARBAPENEM; CEPHALOSPORIN; CIPROFLOXACIN; LEVOFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ARTICLE; BACTERIAL STRAIN; BACTERIUM CULTURE; CHRONIC SINUSITIS; ENDOSCOPIC SURGERY; HUMAN; MAJOR CLINICAL STUDY; MEDICAL RECORD; NONHUMAN; OTORHINOLARYNGOLOGY; PREVALENCE; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RHINOSINUSITIS;

EID: 70349588359     PISSN: 03011569     EISSN: None     Source Type: Journal    
DOI: 10.1159/000316626     Document Type: Erratum

References (21)

1. Fridkin SK, Hill HA, Volkova NV, et al: Temporal changes in prevalence of antimicrobial resistance in 23 US hospitals. Emerg Infect Dis 2002; 8: 697-701.
2. Polk RE, Johnson CK, McClish D, et al: Predicting hospital rates of fluoroquinolone-resistant Pseudomonas aeruginosa from fluoroquinolone use in US hospitals and their surrounding communities. Clin Infect Dis 2004; 39: 497-503.
3. Hsu DI, Okamoto MP, Murthy R, et al: Fluoroquinolone- resistant Pseudomonas aeruginosa: Risk factors for acquisition and impact on outcomes. J Antimicrob Chemother 2005; 55: 535-541.
4. Oudhuis GJ, Verbon A, Hoogkamp-Korstanje JA, et al: Antimicrobial resistance in Escherichia coli and Pseudomonas aeruginosa from Intensive Care Units in The Netherlands, 1998-2005. Int J Antimicrob Agents 2008; 31: 58-63.
5. Zhanel GG, DeCorby M, Laing N, et al: Antimicrobial- resistant pathogens in intensive care units in Canada: Results of the Canadian National Intensive Care Unit (CAN-ICU) study, 2005-2006. Antimicrob Agents Chemother 2008; 52: 1430-1437.
6. Gasink LB, Fishman NO, Weiner MG, et al: Fluoroquinolone-resistant Pseudomonas aeruginosa: Assessment of risk factors and clinical impact. Am J Med 2006; 119: 526.e19- e25.
7. Neuhauser MM, Weinstein RA, Rydman R, et al: Antibiotic resistance among Gramnegative bacilli in US intensive care units: Implications for fluoroquinolone use. JAMA 2003; 289: 885-888.
8. Murray PR, Baron EJ, Jorgensen JH, et al: Manual of Clinical Microbiology, ed 9. Washington, American Society of Microbiology Press, 2007.
9. Clinical and Laboratory Standards Institute: Performance standards for antimicrobial susceptibility testing; fourteenth informational supplement. NCCLS document M100-S14. Wayne, Clinical and Laboratory Standards Institute, 2004.
10. Mesaros N, Nordmann P, Plesiat P, et al: Pseudomonas aeruginosa: Resistance and therapeutic options at the turn of the new millennium. Clin Microbiol Infect 2007; 13: 560-578. (Pubitemid 46730662)
11. Nadel DM, Lanza DC, Kennedy DW: Endoscopically guided cultures in chronic sinusitis. Am J Rhinol 1998; 12: 233-241.
12. Al-Shemari H, Abou-Hamad W, Libman M, et al: Bacteriology of the sinus cavities of asymptomatic individuals after endoscopic sinus surgery. J Otolaryngol 2007; 36: 43-48.
13. Hooper DC: Emerging mechanisms of fluoroquinolone resistance. Emerg Infect Dis 2001; 7: 337-341.
14. Furuya EY, Lowy FD: Antimicrobial-resistant bacteria in the community setting. Nat Rev Microbiol 2006; 4: 36-45.
15. Murray TS, Egan M, Kazmierczak BI: Pseudomonas aeruginosa chronic colonization in cystic fibrosis patients. Curr Opin Pediatr 2007; 19: 83-88.
16. Aaron SD, Ferris W, Ramotar K, et al: Single and combination antibiotic susceptibilities of planktonic, adherent, and biofilm-grown Pseudomonas aeruginosa isolates cultured from sputa of adults with cystic fibrosis. J Clin Microbiol 2002; 40: 4172-4179.
17. Fridkin SK, Steward CD, Edwards JR, et al: Surveillance of antimicrobial use and antimicrobial resistance in United States hospitals: Project ICARE phase 2. Project Intensive Care Antimicrobial Resistance Epide - miology (ICARE) hospitals. Clin Infect Dis 1999; 29: 245-252.
18. Aeschlimann JR: The role of multidrug efflux pumps in the antibiotic resistance of Pseudomonas aeruginosa and other Gramnegative bacteria. Pharmacotherapy 2003; 23: 916-924.
19. Ratjen F: Treatment of early Pseudomonas aeruginosa infection in patients with cystic fibrosis. Curr Opin Pulm Med 2006; 12: 428-432.
20. Ohyama M, Furuta S, Ueno K, et al: Ofloxacin otic solution in patients with otitis media: An analysis of drug concentrations. Arch Otolaryngol Head Neck Surg 1999; 125: 337-340.
21. Chiu AG, Palmer JN, Woodworth BA, et al: Baby shampoo nasal irrigations for the symptomatic post-functional endoscopic sinus surgery patient. Am J Rhinol 2008; 22: 34-37.